Authors : Noreen Munshi, Noreen Munshi, Krishnendra Varma, Krishnendra Varma
DOI : 10.18231/j.ijced.2022.050
Volume : 8
Issue : 4
Year : 2022
Page No : 248-251
Background: The majority of treatments for skin warts include destructive techniques like electrocautery and cryotherapy. These techniques of treatment frequently result in recurrence and scarring. Examining the safety and efficiency of intralesional vitamin D3 injection in cutaneous warts is the goal of this study.
Materials and Methods: Total 50 people with recalcitrant warts of different dimensions, frequencies, and longevity participated in the study. 0.2 to 0.5 ml of vitamin D3 (600,000 IU, 15 mg/ml) were injected into the bases of warts. A maximum of 5 warts were administered per session, with sessions occurring every 2 weeks till the warts vanished, or for a total of 3 sessions. Following the final injection, individuals were monitored for six months to look for any recurrence.
Results: The trial was completed by 50 patients. Out of 50 patients, 35 (or 70%) showed a complete reaction, five (10%) showed a partial response, and ten (10%) showed no response. In every case, the distant warts completely disappeared.
Conclusion: A safe, effective, and affordable therapy option for resistant warts is intralesional vitamin D3.
Keywords: Vitamin D3, Intralesional treatment, Cutaneous warts